Pharmabotix uses Yaskawa’s Motoman HD8 Hygienic Design Robot for filling smaller batches
Personalized medicine – automated filling
Personalized medicine means an elementary change for the pharma and biotech industry aimed at the production of large quantities. Pharmabotix is developing automation and robotics solutions for filling smaller batches as they occur in cell and gene therapy. The Swiss company is thereby focusing on a hygienically designed Yaskawa Motoman HD8 industrial robot.
Advances in cell and gene therapy make it possible for treatments – and thus also drugs – to be individually tailored to the respective patient. These are referred to as “advanced therapy medicinal products” – in short ATMPs – or drugs for advanced therapies. Live cells or defective genes are taken from the patient, processed in the laboratory and then administered again. In this way, diseases can be treated or prevented, and even damaged tissue or organs regenerated and replaced.
“Personalized medicine means that the batch sizes of biopharmaceutical products are increasingly smaller and they are not always bottled in traditional vials or syringes,” explains Fabian Stutz, CEO of Pharmabotix. His company, which specializes in robotics and automation solutions for the pharmaceutical industry, is based in Seengen / Switzerland. Under the brand name “Sally”, Pharmabotix markets various modules for the cell and gene therapy market and lab sector.